ContextVision – key information relating to share split
STOCKHOLM – Aug 13, 2020 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, today announces key information relating to the share spilt after a decision by the Board of Directors as of August 12th 2020. Reference is made to the extraordinary general meeting of ContextVision, held on August 5th, 2020 where it was decided to increase the number of shares in the company by dividing each share into ten shares (share split 10:1). The Board of Directors was authorized to determine the record date for the share split. The Board of Directors decided on a board meeting on August 12, 2020 that the record date for the share split shall be Thursday August 20, 2020.
As a result of the share split the shares in ContextVision AB will change ISIN code. New ISIN code will be SE0014731154. Following the share split the total number of shares in ContextVision will be 77,367,500.
Please note the following key dates for the share split.
Date on which the corporate action was made public: 5 August 2020
Split ratio: 1 old share will give 10 new shares
Last day including right to have 1 share traded into 10 shares: 18 August 2020
Ex-date: 19 August 2020
Record date: 20 August 2020
Date of approval: 12 August 2020
Other information: In conjunction with the share split the ISIN code for ContextVision will be changed to SE0014731154.
About ContextVision
ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X-ray and MRI equipment around the world.
Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment.
ContextVision is now entering the fast-growing digital pathology market. We are re-investing significantly in our product portfolio of decision support tools and we are dedicated to becoming a leading resource for pathologists to radically develop cancer diagnosis and improve patient care.
The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker COV.
For further information, please contact ContextVision’s CEO, Fredrik Palm, at +46 76 870 25 43 or visit www.contextvision.com.
This information is published in accordance with the requirements of the Continuing Obligations.
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.
Attachment
About GlobeNewswire
GlobeNewswireGlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
SEK TENDER OPERATION ANNOUNCEMENT FOR ONWARD LENDING30.9.2020 16:20:00 CEST | Press release
SEK TENDER OPERATION ANNOUNCEMENT FOR ONWARD LENDING 2020-10-02 Transaction type:SEK CreditTender date:2020-10-02Time for submission of bids:10.30-11.00 (CEST)Payment date:2020-10-06Final repayment date2024-10-07Offered volume:50 billion SEKMinimum bid amount:10 million SEKMaximum bid amount:12.5 billion SEKMaximum number of bids from each participant: 1Interest rate:0.00 %Additional interest rate:0.10 per cent ALL APPROVED COUNTERPARTIES ARE INVITED TO SUBMIT VOLUME BIDS TO THE RIKSBANK (46-8-6966970) BY 11.00 ON OCTOBER 2 2020, AT THE LATEST. CONFIRMATION ON E-MAIL: eol@riksbank.se Result of the auction will be published at 11.30 (CEST) on Tender date. Complete terms and conditions can be retrieved at http://www.riksbank.se
Auction details government bonds30.9.2020 16:20:00 CEST | Press release
Auction date October 7, 2020 Maturity date Loan ISIN code Coupon Issue volume, SEK million 2028-05-12 1060 SE0009496367 0.75% 4,000 2032-06-01 1056 SE0004517290 2,25% 1,000 Settlement date October 9, 2020 Bids have to be entered by 11.00 on October 7, 2020 Bid only through dealers approved by the Swedish National Debt Office For more information, please contact: The funding desk + 46 8 613 4780 FO@riksgalden.se
Change in numbers of shares and votes in Saniona AB (publ)30.9.2020 16:00:00 CEST | Press release
PRESS RELEASE September 30, 2020 During September, the registered number of shares and votes in Saniona AB (publ) (“Saniona”) has increased due to the exercising of warrants of series TO 2. As of September 30, 2020, the registered number of shares and votes in Saniona amounts to 62,372,831. For more information, please contact Trista Morrison, Chief Communications Officer. Mobile + 1 (858) 229 1738. Email: trista.morrison@saniona.com This information is such information as Saniona AB (publ) is obliged to make public pursuant to the Swedish Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact person set out above, at 4 p.m. CET on September 30, 2020. About Saniona Saniona is a rare disease biopharmaceutical company focused on research, development and commercialization of treatments for the central nervous system. The company has four programs in clinical development. Saniona intends to develop and commercialize treatments f
Ändring av antalet aktier och röster i Saniona AB (publ)30.9.2020 16:00:00 CEST | Pressemelding
PRESSMEDDELANDE 30 september 2020 Under september månad har det registrerade antalet aktier och röster i Saniona AB (publ) (”Saniona”) ökat till följd av utnyttjandet av teckningsoptioner av serie TO 2. Per den 30 september 2020 uppgår antalet registrerade aktier och röster i Saniona till 62 372 831. För mer information, vänligen kontakta Trista Morrison, Chief Communications Officer. Telefon + 1 (858) 229 1738. Epost: trista.morrison@saniona.com Denna information är sådan information som Saniona AB (publ) är skyldig att offentliggöra enligt lagen om handel med finansiella instrument. Informationen lämnades för offentliggörande via kontaktpersonen som anges ovan, klockan 16:00 CET den 30 september 2020. Om Saniona Saniona är ett biofarmaceutiskt företag som fokuserar på forskning, utveckling och kommersialisering av behandlingar mot sällsynta sjukdomar i centrala nervsystemet. Bolaget har fyra program i klinisk utveckling. Saniona har för avsikt att utveckla och kommersialisera behandl
Auriant Mining AB (publ.) announces changes in its geological team30.9.2020 14:10:09 CEST | Press release
The Board of Directors of Auriant Mining AB (publ.) (the “Company”) announces the departure of Chief Geologist Vladimir Churin, who leaves the Company to pursue other opportunities, and consequent changes in its geological team. The Board is reviewing its future requirements in this team, which in the meantime will continue under the leadership of Senior Geologist, Artem Manshin who has been with the Company for 7 years. Danilo Lange, CEO of Auriant Mining said: “On behalf of Auriant, I would like to thank Vladimir for his service to the Company and the role he has played in developing our asset portfolio, and in particular the successful exploration of the Barsuchiy and Pravoberezhny deposits. We wish him well in his future career. Our review is being carried out as the Board works to ensure we achieve the right balance of skills across all our core disciplines, as the Company prepares for the next stage of its development and in particular unlocking further value in its Tardan and Ka
Auriant Mining AB (publ.) tillkännager förändringar i geologigruppen30.9.2020 14:10:09 CEST | Pressemelding
Styrelsen för Auriant Mining AB (publ.) (”Bolaget”) meddelar avgång av chefsgeolog, Vladimir Churin, som lämnar Bolaget för att utöva andra möjligheter och till följd av förändringar i geologigruppen. Styrelsen arbetar med en översyn av sina framtida krav i detta team, som under den tiden kommer att fortsätta under ledning av seniorgeolog, Artem Manshin, som har varit anställd i Bolaget i 7 år. Danilo Lange, VD för Auriant Mining, kommenterade: ”På uppdrag av Auriant, vill jag tacka Vladimir för hans tjänst till Bolaget och den roll han har spelat för att utveckla vår tillgångsportfölj och i synnerhet den framgångsrika prospekteringen av fyndigheterna Barsuchiy och Pravoberezhny. Vi önskar honom lycka till i sin framtida karriär. Vår granskning genomförs när styrelsen arbetar för att säkerställa att vi uppnår rätt kompetensbalans inom alla våra kärnområden, eftersom Bolaget förbereder sig för nästa steg i sin utveckling och särskilt upplåsning av ytterligare värde av sina tillgångar i